Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential

Juan Bayo, Maithili P. Dalvi, Elisabeth D. Martinez

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

As a class, epigenetic enzymes have been identified as clear targets for cancer therapeutics based on their broad hyperactivity in solid and hematological malignancies. The search for effective inhibitors of histone writers and of histone erasers has been a focus of drug discovery efforts both in academic and pharmaceutical laboratories and has led to the identification of some promising leads. This review focuses on the discovery strategies and preclinical evaluation studies of a subset of the more advanced compounds that target histone writers or histone erasers. The specificity and anticancer potential of these small molecules is discussed within the context of their development pipeline.

Original languageEnglish (US)
Pages (from-to)2243-2261
Number of pages19
JournalFuture Medicinal Chemistry
Volume7
Issue number16
DOIs
StatePublished - Oct 1 2015

Fingerprint

Epigenomics
Histones
Hematologic Neoplasms
Drug Discovery
Enzymes
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential. / Bayo, Juan; Dalvi, Maithili P.; Martinez, Elisabeth D.

In: Future Medicinal Chemistry, Vol. 7, No. 16, 01.10.2015, p. 2243-2261.

Research output: Contribution to journalArticle

@article{8be3869b526e440281e1cfda4390162b,
title = "Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential",
abstract = "As a class, epigenetic enzymes have been identified as clear targets for cancer therapeutics based on their broad hyperactivity in solid and hematological malignancies. The search for effective inhibitors of histone writers and of histone erasers has been a focus of drug discovery efforts both in academic and pharmaceutical laboratories and has led to the identification of some promising leads. This review focuses on the discovery strategies and preclinical evaluation studies of a subset of the more advanced compounds that target histone writers or histone erasers. The specificity and anticancer potential of these small molecules is discussed within the context of their development pipeline.",
author = "Juan Bayo and Dalvi, {Maithili P.} and Martinez, {Elisabeth D.}",
year = "2015",
month = "10",
day = "1",
doi = "10.4155/fmc.15.140",
language = "English (US)",
volume = "7",
pages = "2243--2261",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "16",

}

TY - JOUR

T1 - Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential

AU - Bayo, Juan

AU - Dalvi, Maithili P.

AU - Martinez, Elisabeth D.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - As a class, epigenetic enzymes have been identified as clear targets for cancer therapeutics based on their broad hyperactivity in solid and hematological malignancies. The search for effective inhibitors of histone writers and of histone erasers has been a focus of drug discovery efforts both in academic and pharmaceutical laboratories and has led to the identification of some promising leads. This review focuses on the discovery strategies and preclinical evaluation studies of a subset of the more advanced compounds that target histone writers or histone erasers. The specificity and anticancer potential of these small molecules is discussed within the context of their development pipeline.

AB - As a class, epigenetic enzymes have been identified as clear targets for cancer therapeutics based on their broad hyperactivity in solid and hematological malignancies. The search for effective inhibitors of histone writers and of histone erasers has been a focus of drug discovery efforts both in academic and pharmaceutical laboratories and has led to the identification of some promising leads. This review focuses on the discovery strategies and preclinical evaluation studies of a subset of the more advanced compounds that target histone writers or histone erasers. The specificity and anticancer potential of these small molecules is discussed within the context of their development pipeline.

UR - http://www.scopus.com/inward/record.url?scp=84947601296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947601296&partnerID=8YFLogxK

U2 - 10.4155/fmc.15.140

DO - 10.4155/fmc.15.140

M3 - Article

C2 - 26510529

AN - SCOPUS:84947601296

VL - 7

SP - 2243

EP - 2261

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 16

ER -